TumorBoardTuesday · @TumorBoardTuesday
114 followers · 2306 posts · Server mstdn.science
RT @shilpaonc
4/ #TumorBoardTuesday #BonumCE
#RenalCell #NephTwitter #MedTwitter
Let’s revisit efficacy of 🔑Ph3 clin trials:
💎#CLEAR
💎#KEYNOTE426
💎#CheckMate9ER
💎#CheckMate214
#bonumce #renalcell #NephTwitter #medtwitter #clear #keynote426 #checkmate9er #checkmate214 #TumorBoardTuesday
TumorBoardTuesday · @TumorBoardTuesday
114 followers · 2306 posts · Server mstdn.science
4/ #TumorBoardTuesday #BonumCE
#RenalCell #NephTwitter #MedTwitter
Let’s revisit efficacy of 🔑Ph3 clin trials:
💎#CLEAR
💎#KEYNOTE426
💎#CheckMate9ER
💎#CheckMate214
#TumorBoardTuesday #bonumce #renalcell #NephTwitter #medtwitter #clear #keynote426 #checkmate9er #checkmate214
TumorBoardTuesday · @TumorBoardTuesday
114 followers · 2306 posts · Server mstdn.science
RT @TumorBoardTues
13/#TumorBoardTuesday #BonumCE #RenalCell
#OncTwitter #NephTwitter #MedTwitter
🔬Common tox in pivotal P3 #CHECKMATE214 trial of dual ICI combo🔬
🔸Fatigue
🔹Pruritus
🔸Diarrhea
🔹Rash
🔸Nausea
#bonumce #renalcell #OncTwitter #NephTwitter #medtwitter #checkmate214
TumorBoardTuesday · @TumorBoardTuesday
114 followers · 2306 posts · Server mstdn.science
RT @TumorBoardTues
6/ #TumorBoardTuesday #BonumCE #OncTwitter #NephTwitter #MedTwitter #RenalCell
✳️Dual ICI combo (ipi + nivo) also approved tx option
💎#CheckMate214 - ipi + nivo vs sunitinib
✅Longest follow-up in frontline RCC (>5 years)
✅OS and PFS favor combo tx in int/poor risk pts
#TumorBoardTuesday #bonumce #OncTwitter #NephTwitter #medtwitter #renalcell #checkmate214
TumorBoardTuesday · @TumorBoardTuesday
114 followers · 2306 posts · Server mstdn.science
RT @TumorBoardTues
5/#TumorBoardTuesday #RenalCell
🔑Ph3 trls #KEYNOTE426, #CLEAR, #CheckMate9ER, #CheckMate214
💎Each combo regimen ⬆️PFS, OS, & ORR vs sunitinib
💎Axi-avelumab approved but OS data immature
💎Benefit across IMDC risk groups
💎Axi-pembro=longest f/u among approved TKI-ICI in RCC
#renalcell #keynote426 #clear #checkmate9er #checkmate214
TumorBoardTuesday · @TumorBoardTuesday
114 followers · 2306 posts · Server mstdn.science
13/#TumorBoardTuesday #BonumCE #RenalCell
#OncTwitter #NephTwitter #MedTwitter
🔬Common tox in pivotal P3 #CHECKMATE214 trial of dual ICI combo🔬
🔸Fatigue
🔹Pruritus
🔸Diarrhea
🔹Rash
🔸Nausea
#bonumce #renalcell #OncTwitter #NephTwitter #medtwitter #checkmate214
TumorBoardTuesday · @TumorBoardTuesday
114 followers · 2306 posts · Server mstdn.science
6/ #TumorBoardTuesday #BonumCE #OncTwitter #NephTwitter #MedTwitter #RenalCell
✳️Dual ICI combo (ipi + nivo) also approved tx option
💎#CheckMate214 - ipi + nivo vs sunitinib
✅Longest follow-up in frontline RCC (>5 years)
✅OS and PFS favor combo tx in int/poor risk pts
#TumorBoardTuesday #bonumce #OncTwitter #NephTwitter #medtwitter #renalcell #checkmate214
TumorBoardTuesday · @TumorBoardTuesday
114 followers · 2306 posts · Server mstdn.science
5/#TumorBoardTuesday #RenalCell
🔑Ph3 trls #KEYNOTE426, #CLEAR, #CheckMate9ER, #CheckMate214
💎Each combo regimen ⬆️PFS, OS, & ORR vs sunitinib
💎Axi-avelumab approved but OS data immature
💎Benefit across IMDC risk groups
💎Axi-pembro=longest f/u among approved TKI-ICI in RCC
#renalcell #keynote426 #clear #checkmate9er #checkmate214